Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy

详细信息    查看全文

• 作者：Barbra S. Miller ; MD^a ; ^{barbram@umich.edu} ; Paul G. Gauger ; MD^a ; Gary D. Hammer ; MD ; PhD^b ; Gerard M. Doherty ; MD^c
• 刊名：Surgery
• 出版年：2012
• 出版时间：December, 2012
• 年：2012
• 卷：152
• 期：6
• 页码：1150-1157
• 全文大小：200 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencesding=""UTF-8""?>

Background

Controversy surrounds the use of laparoscopy for resection of adrenocortical carcinoma. We evaluated the hypothesis that outcome is equivalent in patients undergoing laparoscopic adrenalectomy versus open adrenalectomy.

Methods

This is a retrospective review of 217 patients (156 patients with stage I-III cancer) with adrenocortical carcinoma referred to a single institution between 2005 and 2011. Outcome and operative data were assessed for the subset undergoing resection with curative intent. Student t and Fisher exact tests and the Kaplan-Meier method were used to compare data (P ¡Ü .05 was considered statistically significant).

Results

One hundred fifty-six patients (64 % female; median age, 47 years [range, 18-80]; median follow-up, 26.5 months [range, 1-188]) were identified. Forty-six patients underwent laparoscopic adrenalectomy, and 110 underwent open adrenalectomy. Twenty-seven percent of laparoscopic adrenalectomy patients had stage III cancer. After laparoscopic adrenalectomy, 30 % had positive margins or intraoperative tumor spill compared to 16 % of the open adrenalectomy patients (P = .04). Overall survival for patients with stage II cancer was longer in those undergoing open adrenalectomy (P?= .002). Time to visible tumor bed recurrence or peritoneal recurrence in stage II patients was shorter in laparoscopic adrenalectomy patients (P = .002).

Conclusion

Open adrenalectomy is superior to laparoscopic adrenalectomy for adrenocortical carcinoma based on completeness of resection, site and timing of initial tumor recurrence, and survival in stage II patients. Intraoperative evaluation is insensitive for the detection of stage III tumors.